secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHINA PHARMA HOLDINGS, INC. (CPHI)
CIK:        0001106644
Form:       8-K
Filed at:   2022-12-02T23:59:59+00:00
Accession:  0001213900-22-077304
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

China Pharma receives NYSE American deficiency notice for equity shortfall
--------------------------------------------------------------------------

- Stockholders' equity of $2.8M as of Sept 30, 2022 below the $4.0M minimum required by Section 1003(a)(ii).
- Company has reported net losses in four most recent fiscal years ended Dec 31, 2021.
- Must regain compliance with equity standard by Dec 15, 2023, and price noncompliance by March 26, 2023.
- NYSE American accepted a plan on Aug 29, 2022 to cure equity noncompliance; failure to progress may trigger delisting.
- Common stock (CPHI) continues trading with .BC indicator while company attempts to cure deficiencies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1106644/000121390022077304/0001213900-22-077304-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1106644/000121390022077304/ea169585-8k_chinapharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-077304

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer